Global Burden of the Key Components of Cardiovascular-Kidney-Metabolic Syndrome

Zhaomin Xie1, Chaolun Yu2, Qingmei Cui1

  • 1Global Health Research Center, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.

Insights

Cardiovascular-kidney-metabolic (CKM) syndrome poses a growing global health challenge. This study quantifies its burden, revealing increasing DALYs driven by population growth and aging, with significant regional variations.

Area of Science:

  • Global Health
  • Epidemiology
  • Metabolic Diseases

Background:

  • Cardiovascular-kidney-metabolic (CKM) syndrome links metabolic diseases, chronic kidney disease (CKD), and cardiovascular diseases.
  • It represents a significant and escalating global public health concern.

Purpose of the Study:

  • To quantify the global burden of CKM syndrome and its key components.
  • To analyze trends and project future burden through 2046.

Main Methods:

  • Utilized data from the Global Burden of Disease 2019 study.
  • Employed decomposition analysis for population growth, aging, and epidemiologic changes.
  • Applied a NORDPRED model for future burden projections.

Main Results:

  • Ischemic heart disease and stroke were major contributors to CKM burden in 2021.
  • Middle sociodemographic index regions showed the largest burden, while lower SDI regions had higher age-standardized DALY rates.
  • DALYs increased from 1990-2021 due to population growth and aging; diabetes and high body mass index showed increasing trends, while stroke, PAD, and IHD declined.
  • Future projections indicate a continued increase in CKM syndrome burden through 2046.

Conclusions:

  • The study underscores the substantial and increasing global burden of CKM syndrome.
  • Findings highlight the need for targeted interventions and public health strategies to address this complex syndrome.
Abstract

No abstract available in PubMed .

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
External Anatomy of the Kidney01:21

External Anatomy of the Kidney

The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
678
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363